/Companies

Applied BioMath

Winchester, US · Founded 2013 · Delaware LLC

Find your way into Applied BioMath

Sign up to see every warm intro you have to Applied BioMath

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Applied BioMath team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Applied BioMath (now part of Certara) provides Quantitative Systems Pharmacology (QSP) consulting services that combine computational modeling with experimental data to address drug development challenges such as first-in-human dose selection. Its work spans therapeutic areas including oncology, inflammation and immunology, and neurodegenerative diseases, serving biopharmaceutical drug developers.

Founders & leadership

Applied BioMath was founded in 2013 by John Burke and Joshua Apgar.

JBJohn Burke
John BurkeManagerJohn Burke holds a PhD in Mathematics from Arizona State University and completed postdoctoral research in biological engineering at MIT and systems biology at Harvard Medical School. He co-founded Applied BioMath, which he led as CEO before it was acquired by Certara in 2023, and previously headed the Systems Modeling group at Boehringer Ingelheim.
JA
Joshua ApgarManager
ASAndrew Sutherland
Andrew SutherlandManager
VK
Vihann KongManager

Board

PS
Peter SorgerManager

Reported raises · per SEC filings

Form D private placements

$1.5M disclosed across 3 rounds · 2014–2020

▶$25KraisedFeb 2020 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Vihann KongDirector
  • John BurkeDirector
  • Joshua ApgarDirector
  • Andrew SutherlandDirector
  • Peter SorgerDirector
Offering amount
$4.1M
Amount sold
$25K
Minimum investment
$25K
First sale
Feb 2020
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$505.2KraisedMay 2015 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew SutherlandDirector
  • John BurkeDirector
  • Joshua ApgarDirector
  • Vihann KongDirector
  • Peter SorgerDirector
Offering amount
$1M
Amount sold
$505.2K
Minimum investment
$150K
Proceeds to insiders
$600K
First sale
May 2015
Incorporated
Limited Liability Company, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$930KraisedJan 2014 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John BurkeDirector
  • Andrew SutherlandDirector
  • Joshua ApgarDirector
Offering amount
$1.5M
Amount sold
$930K
Minimum investment
$10K
First sale
Jan 2014
Incorporated
Limited Liability Company, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 6 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$300K
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$1.5M
Food and Drug Administration (FDA)Food and Drug AdministrationPhase I2019$150K
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$188.4K
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$1.5M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Applied BioMath do?
Applied BioMath (now part of Certara) provides Quantitative Systems Pharmacology (QSP) consulting services that combine computational modeling with experimental data to address drug development challenges such as first-in-human dose selection. Its work spans therapeutic areas including oncology, inflammation and immunology, and neurodegenerative diseases, serving biopharmaceutical drug developers.
Who founded Applied BioMath?
Applied BioMath was founded by John Burke, Joshua Apgar in 2013.
How much funding has Applied BioMath raised?
Applied BioMath has disclosed $1.5M raised across 3 rounds.
Where is Applied BioMath headquartered?
Applied BioMath is headquartered in Winchester, US.